Search

everythinglearnresearchcommunity

for

Search:↓

Two teenage boys lost hair after taking a drug for growth, which was not a known side effect for kids.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Secondary aesthetic surgeries for gender reassignment are generally satisfying and advance overall aesthetic surgery techniques, but psychological support is important.

Hair loss can lead to significant stigma and lower quality of life, especially for women and those with certain types of alopecia.

Testosterone is crucial for development, growth, and various body functions in mammals.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

New therapies are being developed that target integrin pathways to treat various diseases.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Accurate diagnosis and personalized treatment are crucial for managing women's hair loss.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

PCOS may increase the risk of certain cancers.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

Tamoxifen effectively treats gynecomastia without causing impotence.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.